IMARA INC (IMRA) Stock Price, Quote, News and Overview
NASDAQ:IMRA - Nasdaq - US45249V1070 - Common Stock - Currency: USD
IMRA Quote, Performance and Key Statistics
6.32
+0.87 (+15.96%)
The current stock price of IMRA is 6.32 USD. In the past month the price increased by 50.48%. In the past year, price increased by 321.33%.
IMRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.44 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.58 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.78 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About IMRA
Company Profile
Imara, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Brookline, Massachusetts and currently employs 6 full-time employees. The company went IPO on 2020-03-12. The firm is focused on developing and commercializing therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases. Its lead product candidate, tovinontrine (IMR-687), is an oral, highly selective, potent small molecule inhibitor of phosphodiesterase-9 (PDE9). PDE9 selectively degrades cyclic guanosine monophosphate (cGMP), an active signaling molecule. IMR-687 is in Phase IIb clinical development for the treatment of sickle cell disease (SCD) and beta- thalassemia. The company is also focused on initiating a Phase II clinical trial of IMR-687 in heart failure with preserved ejection fraction (HFpEF). The firm is also focused on development of IMR-261, an oral, clinic-ready activator of nuclear factor erythroid 2-related factor 2 (Nrf2).
Company Info
IMARA INC
1309 Beacon Street, Suite 300
Brookline MASSACHUSETTS 02116 US
CEO: Rahul D. Ballal
Employees: 6
Company Website: https://imaratx.com/
Phone: 16172062020.0
IMARA INC / IMRA FAQ
What is the stock price of IMARA INC today?
The current stock price of IMRA is 6.32 USD. The price increased by 15.96% in the last trading session.
What is the ticker symbol for IMARA INC stock?
The exchange symbol of IMARA INC is IMRA and it is listed on the Nasdaq exchange.
On which exchange is IMRA stock listed?
IMRA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for IMARA INC stock?
6 analysts have analysed IMRA and the average price target is 1.43 USD. This implies a price decrease of -77.41% is expected in the next year compared to the current price of 6.32. Check the IMARA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is IMARA INC worth?
IMARA INC (IMRA) has a market capitalization of 165.80M USD. This makes IMRA a Micro Cap stock.
How many employees does IMARA INC have?
IMARA INC (IMRA) currently has 6 employees.
What are the support and resistance levels for IMARA INC (IMRA) stock?
IMARA INC (IMRA) has a support level at 5.31. Check the full technical report for a detailed analysis of IMRA support and resistance levels.
Should I buy IMARA INC (IMRA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IMRA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IMRA, evaluating the profitability, health, valuation and growth aspects
- IMARA INC (IMRA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IMARA INC (IMRA) Sales and EPS estimates to see what analysts future expectations are.
- IMARA INC (IMRA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IMARA INC (IMRA) Insider and Institutional Ownership to learn about the owners and their transactions.
- IMARA INC (IMRA) Stock Chart to make your own analysis
- IMARA INC (IMRA) Latest news and press-releases to stay up to date.
Does IMARA INC (IMRA) stock pay dividends?
IMRA does not pay a dividend.
When does IMARA INC (IMRA) report earnings?
IMARA INC (IMRA) will report earnings on 2023-03-13.
What is the Price/Earnings (PE) ratio of IMARA INC (IMRA)?
IMARA INC (IMRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.71).
IMRA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to IMRA. When comparing the yearly performance of all stocks, IMRA is one of the better performing stocks in the market, outperforming 99.47% of all stocks.
IMRA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to IMRA. While IMRA has a great health rating, there are worries on its profitability.
IMRA Financial Highlights
Over the last trailing twelve months IMRA reported a non-GAAP Earnings per Share(EPS) of -1.71. The EPS increased by 29.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
IMRA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to IMRA. The Buy consensus is the average rating of analysts ratings from 6 analysts.